LIONVILLE, Pa., Oct. 11, 2012 /PRNewswire/ -- West
Pharmaceutical Services, Inc. (NYSE: WST), a global leader in
innovative system and component solutions for injectable drug
administration, today announced that company representatives will
be speaking in several educational sessions and showcasing West's
innovations at the Parenteral Drug Association's Universe of
Pre-filled Syringes & Injection Devices conference in
Las Vegas, October 15-17, 2012, booth #303.
(Logo:
http://photos.prnewswire.com/prnh/20120904/NE65950LOGO )
Experts from West will present on a range of topics related to
innovations in drug packaging and delivery systems that demonstrate
West's commitment to partnering with drug makers to provide drug
delivery and packaging solutions that enable safe, effective
administration to patients.
West will participate in several sessions at PDA:
- New Development of Polymer Syringe (October 16, 3:30 – 4:00
p.m.): Scott Young,
Senior Director, Daikyo Crystal Zenith® (CZ)
Technologies, West, will present on the CZ system, filling capacity
and lessons learned with Ute
Schleyer, Manager, Pharmaceutical Production, Vetter
Pharma-Fertigung.
- Case Studies in Pre-filled Syringe QbD (October 17, 7:20 – 7:40
a.m.): Tibor Hlobik,
Director, Prefillable Syringe Technologies, West, will present on
integrating Quality by Design for prefillable syringe
components.
- Human Factors (October 17,
8:15 – 9:45 a.m.): Graham Reynolds, Vice President, Marketing and
Innovation, West, will moderate a session on human factors in
combination products.
- Case Studies in Human Factors (October 17, 7:20 – 7:40
a.m.): Chris Evans,
Director of Innovation, West, will co-present with Ed Geiselhart, Director, Product Development and
Planning, Insight Product Development, on developing delivery
systems with the end-user and patient journey in mind.
In addition to its educational sessions, West will showcase a
range of the company's innovative drug delivery system technology
platforms*, including the SelfDose™, the ConfiDose®, the SmartDose®
and other delivery systems that meet the dynamic needs of patients
and healthcare providers for safe, effective administration. For
more information on the location and timing of West's presentations
at PDA, please visit the PDA event agenda online here.
West will also exhibit at the American Association of
Pharmaceutical Scientists Annual Meeting & Exposition in
Chicago, October 14-18, 2012, booth #1741. Product
displays will include NovaPure® components for drug packaging and
West's systems and devices for mixing, reconstituting and
transferring drugs. West will present the following poster:
- Characterization of Polymer PFSA Insert Needle System:
Effect of Product Fill Volume and Solution Viscosity on CCI, BLE
and Residual Volume (October
16, 1:30 – 4:30 p.m.):
Lloyd Waxman, Principal Scientist,
West Analytical Laboratories.
"This is an exciting time for the pharmaceutical and biotech
industries, with increasing development of biologics, more generics
coming on the market and growing global demand for innovative drug
delivery technology," said Dr. Mike
Schafers, Vice President, Global Marketing, Pharmaceutical
Packaging Systems, West. "Drug manufacturers are looking for
solutions to bring drug products from concept to the patient more
efficiently, reliably and safely. West is working side-by-side with
drug manufacturers on innovative drug delivery solutions as a key
part of providing patients and healthcare professionals with the
best therapies possible."
About West
West works side-by-side with its healthcare partners from
concept to the patient, designing and manufacturing packaging,
diagnostic and delivery systems that promote the efficiency,
reliability and safety of their products. Every day, West is
leading the way with cutting-edge technologies and quality systems,
a thorough understanding of global regulatory compliance, and an
unmatched and growing knowledge base of relevant pharmaceutical
product testing, development and packaging. Based in Lionville, Pa., West supports its customers
from sales, manufacturing, customer support and research and
development locations in North and South
America, Europe,
Asia and Australia. Established in 1923, West's 2011
sales were $1.2 billion, reflecting
daily use of approximately 100 million of its components and
devices.
Visit West online at http://www.westpharma.com and follow West
on Twitter: http://www.twitter.com/WestPharma.
SelfDose™, ConfiDose® and SmartDose® and NovaPure® are
trademarks or registered trademarks of West Pharmaceutical
Services, Inc. and its subsidiaries in the United States and other
jurisdictions.
Daikyo Crystal Zenith® is a registered trademark of Daikyo
Seiko, Ltd.
Daikyo Crystal Zenith technology is licensed from Daikyo
Seiko, Ltd.
*For investigational use only by our pharmaceutical and
biotechnology development partners.
West markets the SmartDose, ConfiDose and SelfDose as
integrated systems with drug filling and final assembly completed
by the pharmaceutical company.
Media Contact:
Kristin Villiotte
(781) 684-0770
westpharma@schwartzmsl.com
Investor Contact:
Michael A. Anderson
Vice President and Treasurer
(610) 594-3345
Michael.Anderson@westpharma.com
SOURCE West Pharmaceutical Services, Inc.